Rapamycin Inhibits Activation of Ryanodine Receptors from Skeletal Muscle by the Fatty Acyl CoA–Acyl CoA Binding Protein Complex
- 22 October 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 264 (2) , 409-412
- https://doi.org/10.1006/bbrc.1999.1532
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Acyl-Coenzyme A Causes Ca2+ Release in Pancreatic Acinar CellsPublished by Elsevier ,1997
- Fatty acyl-CoA–acyl-CoA-binding protein complexes activate the Ca2+ release channel of skeletal muscle sarcoplasmic reticulumBiochemical Journal, 1997
- Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signallingBiochemical Journal, 1997
- Cellular functions of immunophilinsPhysiological Reviews, 1996
- Palmitoyl-CoA potentiates the Ca2+ release elicited by cyclic ADP-riboseAmerican Journal of Physiology-Cell Physiology, 1996
- Removal of Mg2+ inhibition of cardiac ryanodine receptor by palmitoyl coenzyme AFEBS Letters, 1994
- Effects of palmitoyl carnitine and related metabolites on the avian Ca(2+)‐ATPase and Ca2+ release channel.The Journal of Physiology, 1994
- Fatty acyl-CoA esters induce calcium release from terminal cisternae of skeletal muscleCell Calcium, 1994
- The calcium release channel of sarcoplasmic reticulum is modulated by FK-506 binding protein: Effect of FKBP-12 on single channel activity of the skeletal muscle ryanodine receptorCell Calcium, 1994
- Thirty-seventh Annual Meeting February 14-18, 1993 Washington Convention Center Washington, D.C. Tuesday Symposia and Posters, Part IIIBiophysical Journal, 1993